Valproic Acid Use During Radiation Therapy for Glioblastoma Associated With Improved Survival-Reference-Cited by-同舟云学术

Valproic Acid Use During Radiation Therapy for Glioblastoma Associated With Improved Survival

Published:2013-07 Issue:3 Volume:86 Page:504-509
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Barker Christopher A.,Bishop Andrew J.,Chang Maria,Beal Kathryn,Chan Timothy A.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference21 articles.

1. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumours Diagnosed in the United States in 2004-2008 (March 23, 2012 Revision);CBTRUS,2012

2. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial;Stupp;Lancet Oncol,2009

3. Comprehensive genomic characterization defines human glioblastoma genes and core pathways;Cancer Genome Atlas Research Network;Nature,2008

4. Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity;Munshi;Clin Cancer Res,2005

5. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen;Phiel;J Biol Chem,2001

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design of experiment (DoE) of mucoadhesive valproic acid-loaded nanostructured lipid carriers (NLC) for potential nose-to-brain application;International Journal of Pharmaceutics;2024-10

2. Epigenetic Mechanisms Histone Deacetylase–Dependent Regulate the Glioblastoma Angiogenic Matrisome and Disrupt Endothelial Cell Behavior In Vitro;Molecular & Cellular Proteomics;2024-03

3. Unexplained Causes of Glioma-Associated Epilepsies: A Review of Theories and an Area for Research;Cancers;2023-11-22

4. Identifying patients suitable for targeted adjuvant therapy: advances in the field of developing biomarkers for tumor recurrence following irradiation;Expert Review of Precision Medicine and Drug Development;2023-11-16

5. HDAC1 and HDAC6 are essential for driving growth in IDH1 mutant glioma;Scientific Reports;2023-08-01